We are live on ! Find out more
National Bank of Canada

National Bank of Canada Portfolio holdings

AUM $140B
1-Year Est. Return 46.34%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+46.34%
3 Year Est. Return
+120.97%
5 Year Est. Return
10 Year Est. Return
AUM
$87.3B
AUM Growth
+$14B
Cap. Flow
+$4.99B
Cap. Flow %
5.72%
Top 10 Hldgs %
26.37%
Holding
3,113
New
421
Increased
995
Reduced
902
Closed
382

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$755M
2
AMZN icon
Amazon
AMZN
+$521M
3
AVGO icon
Broadcom
AVGO
+$484M
4
QCOM icon
Qualcomm
QCOM
+$419M
5
RY icon
Royal Bank of Canada
RY
+$383M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Financials 17.39%
3 Industrials 6.79%
4 Healthcare 6.51%
5 Communication Services 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUMZ icon
2601
Zumiez
ZUMZ
$319M
$43 ﹤0.01%
+2
New +$48
BATRA icon
2602
Atlanta Braves Holdings Series A
BATRA
$3.64B
$42 ﹤0.01%
1
BLUE
2603
DELISTED
bluebird bio
BLUE
$42 ﹤0.01%
+4
New +$66
DAVE icon
2604
Dave Inc
DAVE
$4.26B
$40 ﹤0.01%
+1
New +$36
ROOT icon
2605
Root
ROOT
$772M
$38 ﹤0.01%
+1
New +$52
WKHS icon
2606
Workhorse Group
WKHS
$33.1M
-1
Closed -$169
DYN icon
2607
Dyne Therapeutics
DYN
$4.85B
$36 ﹤0.01%
+1
New +$40
EDSA icon
2608
Edesa Biotech
EDSA
$52.3M
$36 ﹤0.01%
8
NE icon
2609
Noble Corp
NE
$7.07B
$36 ﹤0.01%
+1
New +$40
ASM
2610
Avino Silver & Gold Mines
ASM
$1.21B
$35 ﹤0.01%
+32
New +$32
APLT
2611
DELISTED
Applied Therapeutics
APLT
$34 ﹤0.01%
+4
New +$24
ENVB icon
2612
Enveric Biosciences
ENVB
$6.08M
0
DOLE icon
2613
Dole
DOLE
$1.26B
$33 ﹤0.01%
+2
New +$30
TOWN icon
2614
Towne Bank
TOWN
$3.5B
$33 ﹤0.01%
+1
New +$32
ALKT icon
2615
Alkami Technology
ALKT
$2.22B
$32 ﹤0.01%
+1
New +$32
EOLS icon
2616
Evolus
EOLS
$530M
$32 ﹤0.01%
+2
New +$28
ACH
2617
Accendra Health
ACH
$84.6M
$31 ﹤0.01%
2
-48
-96% -$727
SB icon
2618
Safe Bulkers
SB
$781M
$31 ﹤0.01%
+6
New +$31
SASR
2619
DELISTED
Sandy Spring Bancorp Inc
SASR
$31 ﹤0.01%
+1
New +$30
SPIR icon
2620
Spire Global
SPIR
$540M
$30 ﹤0.01%
3
+2
+200% +$21
CSTL icon
2621
Castle Biosciences
CSTL
$933M
$29 ﹤0.01%
+1
New +$25
INGN icon
2622
Inogen
INGN
$154M
$29 ﹤0.01%
+3
New +$31
SPT icon
2623
Sprout Social
SPT
$604M
$29 ﹤0.01%
+1
New +$33
SYRE icon
2624
Spyre Therapeutics
SYRE
$8.98B
$29 ﹤0.01%
+1
New +$28
FFAI
2625
Faraday Future Intelligent Electric
FFAI
$12M
0

Similar funds

National Bank of Canada's Q3 2024 Portfolio in Review

As of Q3 2024, National Bank of Canada held 3,113 positions worth $87.3B, up 19% from $73.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

National Bank of Canada deployed $4.99B of net new capital in Q3 2024, opening 421 new positions and adding to 995 existing holdings. Its largest new stake was Kanzhun: 2,619,912 shares worth $45.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Apple, an estimated $755M trimmed.

  • National Bank of Canada's largest Q3 2024 buy was Kanzhun: 2,619,912 shares worth $45.5M.
  • National Bank of Canada added most to Microsoft in Q3 2024, an estimated $845M increase.
  • National Bank of Canada's biggest Q3 2024 reduction was Apple, cutting an estimated $755M.
  • National Bank of Canada fully exited WestRock Company in Q3 2024, selling an estimated $30.6M.
  • National Bank of Canada's ten largest holdings make up 26% of its $87.3B portfolio in Q3 2024.
  • National Bank of Canada opened 421 new positions and closed 382 in Q3 2024.
  • National Bank of Canada's portfolio value rose 19% quarter-over-quarter to $87.3B.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.